Skip to content
Synopulse
  • The Brief
    • Quick
    • In Depth
    • Editor’s Pick
  • Reports
    • The beats
      • Catalyst
      • AccessWatch
      • DealPulse Signal
      • DealPulse Report
    • Analysis
      • The Throughline
      • The Top Line
      • The Forecast
    • Coverage
      • ShowFloor
      • The Arena
  • The Pulse
    • NeuroPulse
    • OrphanPulse
  • Topics
    • By subject
      • Deals
      • Regulatory
      • Market Access
      • Pricing & Reimbursement
      • Litigation, Law & Policy
    • By technology
      • Antibody
      • Cell & Gene Tx
      • Drug conjugates
      • AI/ML
      • Digital Health
      • Radiopharma
    • By therapy area
      • Neurology
      • Oncology
      • Rare Diseases
      • Cardio-Metabolic
      • Immunology & Inflammation
      • Orthopaedics

Pediatric

The Only Non-Drug Pediatric ADHD Device Launches Its Second Generation Into a 1,500-Family Waitlist

July 22, 2026 by Athithi
The Only Non-Drug Pediatric ADHD Device Launches Its Second Generation Into a 1,500-Family Waitlist

The only FDA-cleared non-drug treatment for pediatric ADHD launched its second generation into a 1,500-family waitlist, with reimbursement still the open question.

Categories Neurology, Quick, Regulatory, The Brief Tags ADHD, MedTech, Monarch eTNS, Neurology, Neuromodulation, NeuroSigma, Pediatric

Crysvita Reaches One-Month-Old Infants in the EU, and Buys Two More Years of Orphan Exclusivity

July 22, 2026 by Athithi
Crysvita Reaches One-Month-Old Infants in the EU, and Buys Two More Years of Orphan Exclusivity

The European Commission approved Crysvita for infants as young as one month with XLH, a decision that also buys Kyowa Kirin two more years of orphan exclusivity.

Categories Antibody, Quick, Rare Diseases, Regulatory, The Brief Tags Burosumab, Crysvita, Kyowa Kirin, Market Access, Orphan Exclusivity, Pediatric, Rare disease, XLH

A Father’s Liver, One Incision: the First Single-Port Robotic Liver Transplant Lands in a Six-Year-Old

July 22, 2026July 22, 2026 by Athithi
A Father’s Liver, One Incision the First Single-Port Robotic Liver Transplant Lands in a Six-Year-Old

A six-year-old with a rare genetic liver disorder became the first patient to receive a liver transplant through a single robotic incision, donated by his father.

Categories Quick, Rare Diseases, The Brief Tags King Faisal Specialist Hospital, Liver transplant, MedTech, Pediatric, Rare disease, Robotic surgery, Saudi Arabia, Wolcott-Rallison syndrome
Synopulse Weekly Pulse: Access Decisions, Regulatory Events & Market Dynamics, Week of Nov 24 2025

Synopulse Weekly Pulse – November 24, 2025

Read Now
  • Antibody
  • Cardio-Metabolic
  • Cell & Gene Tx
  • CI read
  • DealPulse Signal
  • Editor’s Feature
  • In Depth
  • Litigation, Law & Policy
  • Market Access
  • Neurology
  • NeuroPulse
  • News
  • Oncology
  • OrphanPulse
  • Orthopaedics
  • Pricing & Reimbursement
  • Quick
  • Rare Diseases
  • Regulatory
  • Reports
  • The Brief
  • The Pulse
  • July 2026
  • June 2026
  • May 2026
  • March 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • February 2025
  • January 2025
  • October 2024
  • September 2024
Synopulse
Contact Us

Explore Synopulse

  • NeuroPulse
  • Deals
  • Market Access
  • Industry Trends
  • Regulatory

About

  • About Synopulse
  • Contact Us
  • Announcements
© 2026 Synopulse • Built with GeneratePress